Prior to analyze the presence of OCT1 at the plasma membrane in HCC samples collected from these patients, two different antibodies raised against different regions of the protein were tested on healthy liver tissue (Figure 1A–1D). Here, SLC22A1 is linked to hepatocellular carcinoma.